Bank of America
EVFM

Bank of America’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bank of America’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22
Closed – – 8603
2022
Q2 		$0 Sell
22
-136
-86% -$224 ﹤0.01% 8797
2022
Q1 		$1K Buy
158
+132
+508% +$830 ﹤0.01% 8188
2021
Q4 		$0 Sell
26
-16,110
-100% -$137K ﹤0.01% 8952
2021
Q3 		$179K Buy
16,136
+16,106
+53,687% +$202K ﹤0.01% 6377
2021
Q2 		$0 Sell
30
-22,190
-100% -$421K ﹤0.01% 8340
2021
Q1 		$583K Buy
22,220
+21,685
+4,053% +$986K ﹤0.01% 5242
2020
Q4 		$19K Sell
535
-15,952
-97% -$577K ﹤0.01% 6606
2020
Q3 		$583K Buy
16,487
+15,683
+1,951% +$682K ﹤0.01% 4588
2020
Q2 		$35K Buy
804
+263
+49% +$17.7K ﹤0.01% 6117
2020
Q1 		$44K Buy
541
+149
+38% +$11.9K ﹤0.01% 5921
2019
Q4 		$37K Sell
392
-17
-4% -$1.43K ﹤0.01% 6346
2019
Q3 		$31K Buy
409
+222
+119% +$17K ﹤0.01% 6485
2019
Q2 		$19K Buy
+187
New +$14.5K ﹤0.01% 6588
2019
Q1 		– Sell
-1
Closed – – 7533
2018
Q4 		$0 Buy
+1
New +$55 ﹤0.01% 7507
2018
Q2 		– Sell
-124
Closed -$12K – 7421
2018
Q1 		$12K Buy
+124
New +$15.9K ﹤0.01% 6570
2016
Q4 		– Hold
0
– – – 7445
2016
Q3 		– Hold
0
– – – 7457
2016
Q2 		– Hold
0
– – – 7495
2016
Q1 		– Sell
-57
Closed -$7K – 7443
2015
Q4 		$7K Buy
57
+51
+850% +$33.6K ﹤0.01% 6802
2015
Q3 		$4K Buy
+6
New +$6.44K ﹤0.01% 6850

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Bank of America's EVFM Position: Q3 2022 in Review

Bank of America sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 22 shares.

Bank of America first reported a position in EVFM in Q3 2015 and held it in 17 quarters. The position peaked at $583K in Q1 2021. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Bank of America reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Bank of America sold 22 Evofem Biosciences, Inc. Common Stock shares in Q3 2022.
  • Bank of America first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and held it in 17 quarters.
  • Bank of America's Evofem Biosciences, Inc. Common Stock position peaked at $583K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.